Please note: This trial has finished recruiting and is not accepting new participants.
Research Center: Laboratory of Human Behavioral Pharmacology, University of Kentucky
Location: Lexington, Kentucky USA
Lead Doctor: Dr. Craig Rush
Funded By: National Institute on Alcohol Abuse and Alcoholism
IRB Committee: This study has been reviewed and approved by the University of Kentucky Institutional Review Board
Background
Investigators at the University of Kentucky are studying the effects of 2 FDA-approved medications in combination with alcohol.
The knowledge gained from this study will contribute to a better understanding of alcohol use and may result in improved therapeutic treatments.
The study seeks men and women who engage in drinking alcohol at least 3 days per week. Participants are required to attend 8 study visits at the research site over roughly 8 weeks and will be compensated for participating in this study.
Why Participate?
- You will be helping to advance medical research in alcohol use, which may result in improved therapeutic treatments.
- You will be compensated for participating in this study.
Your Rights
- If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
- Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
- Qualified health professionals will monitor your health as it relates to the study.
Who Can Participate?
- Men and women ages 21-55 who consume alcohol at least 3 days per week.
- Not currently seeking or undergoing treatment for alcohol abuse or any other substance abuse.
- Able to attend 8 study visits at the research site over approximately 8 weeks (1 visit per week for 8 consecutive weeks).
- 5 of these visits will last between 4-6 hours
- 3 of these visits are post-study follow-up appointments, lasting approximately 30 minutes
- Not taking any other illicit substances.
- Are healthy and have no major disease processes or major psychiatric disorders.